Developing a Resilient Patient-Centered Clinical Supply Chain

As clinical trials grow in complexity, the need for resilient supply chains is increasingly apparent. The industry is responding by developing flexible new strategies like direct-to-patient distribution and demand-led supply. In a recent Clinical Leader Article by Catalent, these new options and their potential impact on clinical trials are explored.

According to Catalent, “The development of more flexible solutions seeks to strike a balance between not subjecting patients to additional risk, but also maintaining continuity of care through what could be life-changing, and in some cases, life-saving clinical studies by preventing treatment delays due to a shortage of clinical supplies when and where needed.”

To learn more, click here.

(Source: Clinical Leader, May 23^rd, 2022)